Progress Adult Study

Depression Clinical Trial

Official title:

The Thai HIV Disease Progression: An Observational Database

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01328275
• Other study ID #: HIV-NAT 153
• Status: Completed
• Phase: N/A
• First received: March 2, 2011
• Last updated: May 9, 2016
• Start date: December 2007
• Est. completion date: June 2015

Study information

• Verified date: May 2016
• Source: The HIV Netherlands Australia Thailand Research Collaboration
• Contact: n/a
• Is FDA regulated: No
• Health authority: Thailand: Ethical Committee
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to study the HIV disease progression in HIV-infected Thai Adult.

Description:

This is a multicenter, observational prospective cohort study. All HIV-infected patients from Bamrasnaradura Institute, Sanpatong Hospital and HIV-NAT, Thai Red Cross AIDS Research Centre, are followed to assess HIV disease progression.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 5600
• Est. completion date: June 2015
• Est. primary completion date: June 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. There is evidence that HIV infection true (blood positive results by ELISA (ELISA) has been confirmed or detected evidence co-infection. HIV in the body by PCR, HIV-RNA PCR).Currently on PI regimens

2. Signed consent form

3. Age> 18 years

Exclusion Criteria:

1. Patients who came for treatment in a department other than out patient, such as inpatient or emergency room.

2. Patients are not willing to receive treatment on a regular basis in all 3 hospitals as patients normally receive treatment at other hospitals on a regular basis. However, due to urgent events. Need to receive treatment in hospital and three of.

3. Patients who have been diagnosed by doctors as a Psychological disorder that can not store the data.

4. Patients who have been diagnosed by a medical condition that Alcoholism

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Depression
• HIV

Intervention

Drug:
• standard regimens according to the Thai Ministry of Public Health national guidelines
Participants may receive any of the standard regimens. These regimens are recommended in the Thai Ministry of Public Health National guidelines for the treatment of HIV in children. Change of treatment will be according to the treating physicians.

Locations

Country	Name	City	State
Thailand	HIV-NAT, Thai Red Cross AIDS Research Centre	Bangkok
Thailand	Sanpatong Hospital	Chiang Mai
Thailand	Bamrasnaradura infectious disease institute	Nonthaburi

Sponsors (3)

Lead Sponsor	Collaborator
The HIV Netherlands Australia Thailand Research Collaboration	Bamrasnaradura Infectious Diseases Institute, Sanpatong Hospital

Country where clinical trial is conducted

Thailand, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	HIV related adverse events	Time until patient has HIV related adverse events	1 year	Yes
Secondary	Immunological failure	time to immunological failure	1 year	Yes
Secondary	virological failure	time to virological failure	1 year	Yes
Secondary	the change of quality of life	time to change of quality of life	1 year	No
Secondary	depression	time when patient develops depression	1 year	No
Secondary	genotypic resistance	time to developing genotypic resistance	1 year	Yes

External Links

•   HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT)